Rani Therapeutics Holdings (RANI) Depreciation and Depletion (2021 - 2026)

Rani Therapeutics Holdings' Depreciation and Depletion history spans 4 years, with the latest figure at $200000.0 for Q1 2026.

  • On a quarterly basis, Depreciation and Depletion fell 33.33% to $200000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $767000.0, a 11.32% increase, with the full-year FY2025 number at $900000.0, down 10.0% from a year prior.
  • Depreciation and Depletion came in at $200000.0 for Q1 2026, down from $300000.0 in the prior quarter.
  • The five-year high for Depreciation and Depletion was $300000.0 in Q1 2025, with the low at $111000.0 in Q1 2022.
  • Historically, Depreciation and Depletion has averaged $166666.7 across 3 years, with a median of $133500.0 in 2022.
  • Biggest five-year swings in Depreciation and Depletion: grew 17.5% in 2022 and later crashed 33.33% in 2026.
  • Year by year, Depreciation and Depletion stood at $126000.0 in 2022, then soared by 138.1% to $300000.0 in 2025, then plummeted by 33.33% to $200000.0 in 2026.
  • Business Quant data shows Depreciation and Depletion for RANI at $200000.0 in Q1 2026, $300000.0 in Q1 2025, and $126000.0 in Q4 2022.